CVE-2022-21146

ICSA-22-062-01 IPCOMM ipDIO

Description

Persistent cross-site scripting in the web interface of ipDIO allows an unauthenticated remote attacker to introduce arbitrary JavaScript by injecting an XSS payload into a specific parameter. The XSS payload will be executed when a legitimate user attempts to review history.

Remediation

Solution:

  • IPCOMM recommends upgrading to its ip4Cloud device, which is the successor to ipDIO. Contact IPCOMM customer support for assistance with the upgrade. For more information, visit the IPCOMM ip4Cloud product page.

Category

6.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.13%
Third-Party Advisory cisa.gov
Affected: IPCOMM IPCOMM ipDIO
Published at:
Updated at:

References

Link Tags
https://www.cisa.gov/uscert/ics/advisories/icsa-22-062-01 us government resource third party advisory mitigation

Frequently Asked Questions

What is the severity of CVE-2022-21146?
CVE-2022-21146 has been scored as a medium severity vulnerability.
How to fix CVE-2022-21146?
To fix CVE-2022-21146: IPCOMM recommends upgrading to its ip4Cloud device, which is the successor to ipDIO. Contact IPCOMM customer support for assistance with the upgrade. For more information, visit the IPCOMM ip4Cloud product page.
Is CVE-2022-21146 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-21146 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-21146?
CVE-2022-21146 affects IPCOMM IPCOMM ipDIO.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.